In April 2026, the FDA announced that its Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23 and 24, 2026, to discuss several peptide-related bulk drug substances for possible inclusion on the 503A Bulks List
Presented for research literature review only Vukusic D et al
Immunohistochemical findings Immunostaining for CD68 and F4/80 was used to assess the early inflammatory response, specifically focusing on macrophage presence within the grafts
A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanol-induced injury
13 Indications for surgical repair The decision to repair a TFCC tear surgically is multifactorial, integrating symptoms, tear characteristics, associated pathology, and patient-specific factors
Glutathione synthesis is the casualty no one talks about